SMTL ID : 4f1f.1

Human Insulin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.68 Å

Oligo State

hetero-6-6-mer

Ligands

6 x ZN: ZINC ION(Non-covalent)

ZN.1: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: CL.2, ZN.5, CL.6, ZN.9, CL.10 3 PLIP interactions: 1 interactions with chain B, 1 interactions with chain J, 1 interactions with chain F Metal complexes: B:H.10, J:H.10, F:H.10 ZN.3: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: CL.4, ZN.7, CL.8, ZN.11, CL.12 3 PLIP interactions: 1 interactions with chain L, 1 interactions with chain D, 1 interactions with chain H Metal complexes: L:H.10, D:H.10, H:H.10 ZN.5: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, CL.6, ZN.9, CL.10 3 PLIP interactions: 1 interactions with chain B, 1 interactions with chain J, 1 interactions with chain F Metal complexes: B:H.10, J:H.10, F:H.10 ZN.7: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: ZN.3, CL.4, CL.8, ZN.11, CL.12 3 PLIP interactions: 1 interactions with chain L, 1 interactions with chain D, 1 interactions with chain H Metal complexes: L:H.10, D:H.10, H:H.10 ZN.9: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, ZN.5, CL.6, CL.10 3 PLIP interactions: 1 interactions with chain B, 1 interactions with chain J, 1 interactions with chain F Metal complexes: B:H.10, J:H.10, F:H.10 ZN.11: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: ZN.3, CL.4, ZN.7, CL.8, CL.12 3 PLIP interactions: 1 interactions with chain L, 1 interactions with chain D, 1 interactions with chain H Metal complexes: L:H.10, D:H.10, H:H.10

6 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, ZN.5, CL.6, ZN.9, CL.10 Ligand excluded by PLIP CL.4: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: ZN.3, ZN.7, CL.8, ZN.11, CL.12 Ligand excluded by PLIP CL.6: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, ZN.5, ZN.9, CL.10 Ligand excluded by PLIP CL.8: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: ZN.3, CL.4, ZN.7, ZN.11, CL.12 Ligand excluded by PLIP CL.10: 8 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: ZN.1, CL.2, ZN.5, CL.6, ZN.9 Ligand excluded by PLIP CL.12: 8 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: ZN.3, CL.4, ZN.7, CL.8, ZN.11 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Favero-Retto, M.P. et al., Structural meta-analysis of regular human insulin in pharmaceutical formulations. Eur J Pharm Biopharm (2013)

Release Date

2013-05-08

Peptides

Insulin A chain: ACEGIK
Insulin B chain: BDFHJL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

E
A

G
C

I
A

K
C

B
B

D
D

F
B

H
D

J
B

L
D

Insulin A chain

Insulin B chain

Related Entries With Identical Sequence